IMAFLEX INC (IFX.CA) Stock Fundamental Analysis

TSX-V:IFX • CA4524352099

2.31 CAD
0 (0%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IFX. IFX was compared to 9 industry peers in the Containers & Packaging industry. IFX has an excellent financial health rating, but there are some minor concerns on its profitability. IFX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • IFX had positive earnings in the past year.
  • IFX had a positive operating cash flow in the past year.
  • Each year in the past 5 years IFX has been profitable.
  • IFX had a positive operating cash flow in each of the past 5 years.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

  • IFX has a worse Return On Assets (1.47%) than 66.67% of its industry peers.
  • IFX has a worse Return On Equity (2.06%) than 66.67% of its industry peers.
  • IFX has a Return On Invested Capital of 4.96%. This is in the lower half of the industry: IFX underperforms 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IFX is in line with the industry average of 7.93%.
Industry RankSector Rank
ROA 1.47%
ROE 2.06%
ROIC 4.96%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a Profit Margin value of 1.24%, IFX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • IFX's Profit Margin has improved in the last couple of years.
  • The Operating Margin of IFX (4.57%) is worse than 77.78% of its industry peers.
  • IFX's Operating Margin has improved in the last couple of years.
  • IFX has a Gross Margin of 14.54%. This is in the lower half of the industry: IFX underperforms 77.78% of its industry peers.
  • IFX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.57%
PM (TTM) 1.24%
GM 14.54%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IFX is destroying value.
  • The number of shares outstanding for IFX remains at a similar level compared to 1 year ago.
  • IFX has more shares outstanding than it did 5 years ago.
  • IFX has a better debt/assets ratio than last year.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • IFX has an Altman-Z score of 5.23. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.23, IFX belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • IFX has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
  • IFX has a Debt to FCF ratio of 0.78. This is amongst the best in the industry. IFX outperforms 88.89% of its industry peers.
  • IFX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • IFX's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. IFX outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.78
Altman-Z 5.23
ROIC/WACC0.62
WACC8.05%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • IFX has a Current Ratio of 2.53. This indicates that IFX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.53, IFX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • A Quick Ratio of 1.72 indicates that IFX should not have too much problems paying its short term obligations.
  • IFX's Quick ratio of 1.72 is fine compared to the rest of the industry. IFX outperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 1.72
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

  • IFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.93%.
  • The Earnings Per Share has been growing by 36.43% on average over the past years. This is a very strong growth
  • IFX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.32%.
  • IFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.26% yearly.
EPS 1Y (TTM)-77.93%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-64.33%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-3.28%

3.2 Future

  • IFX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 116.02% yearly.
  • IFX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.80% yearly.
EPS Next Y33.33%
EPS Next 2Y116.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y6.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 77.00, which means the current valuation is very expensive for IFX.
  • 77.78% of the companies in the same industry are cheaper than IFX, based on the Price/Earnings ratio.
  • IFX is valuated expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 16.02, which indicates a correct valuation of IFX.
  • 66.67% of the companies in the same industry are more expensive than IFX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, IFX is valued a bit cheaper.
Industry RankSector Rank
PE 77
Fwd PE 16.02
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 77.78% of the companies in the same industry are cheaper than IFX, based on the Enterprise Value to EBITDA ratio.
  • IFX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.08
EV/EBITDA 10.81
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IFX does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as IFX's earnings are expected to grow with 116.02% in the coming years.
PEG (NY)2.31
PEG (5Y)2.11
EPS Next 2Y116.02%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • IFX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

IMAFLEX INC

TSX-V:IFX (2/13/2026, 7:00:00 PM)

2.31

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)11-27
Earnings (Next)04-22
Inst Owners19.75%
Inst Owner ChangeN/A
Ins Owners43.18%
Ins Owner ChangeN/A
Market Cap120.33M
Revenue(TTM)108.00M
Net Income(TTM)1.34M
Analysts84.44
Price Target1.73 (-25.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-83.82%
Min EPS beat(2)-100%
Max EPS beat(2)-67.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.78%
Min Revenue beat(2)-16.54%
Max Revenue beat(2)-7.03%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-71.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.09%
Valuation
Industry RankSector Rank
PE 77
Fwd PE 16.02
P/S 1.11
P/FCF 11.08
P/OCF 8.48
P/B 1.86
P/tB 1.93
EV/EBITDA 10.81
EPS(TTM)0.03
EY1.3%
EPS(NY)0.14
Fwd EY6.24%
FCF(TTM)0.21
FCFY9.02%
OCF(TTM)0.27
OCFY11.79%
SpS2.07
BVpS1.24
TBVpS1.2
PEG (NY)2.31
PEG (5Y)2.11
Graham Number0.92
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 2.06%
ROCE 6.65%
ROIC 4.96%
ROICexc 5.91%
ROICexgc 6.14%
OM 4.57%
PM (TTM) 1.24%
GM 14.54%
FCFM 10.05%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
ROICexc(3y)8.55%
ROICexc(5y)12.05%
ROICexgc(3y)8.89%
ROICexgc(5y)12.53%
ROCE(3y)10.53%
ROCE(5y)14.7%
ROICexgc growth 3Y-20.84%
ROICexgc growth 5Y5.88%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y5.71%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
F-Score4
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.78
Debt/EBITDA 0.58
Cap/Depr 56.61%
Cap/Sales 3.08%
Interest Coverage 8.8
Cash Conversion 131.19%
Profit Quality 812.89%
Current Ratio 2.53
Quick Ratio 1.72
Altman-Z 5.23
F-Score4
WACC8.05%
ROIC/WACC0.62
Cap/Depr(3y)236.8%
Cap/Depr(5y)164.27%
Cap/Sales(3y)10.14%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.93%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-64.33%
EPS Next Y33.33%
EPS Next 2Y116.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-3.28%
Revenue Next Year11.68%
Revenue Next 2Y6.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.66%
EBIT growth 3Y-9.43%
EBIT growth 5Y14.73%
EBIT Next Year70.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y280.88%
FCF growth 3Y29.22%
FCF growth 5Y23.11%
OCF growth 1Y100.18%
OCF growth 3Y25.19%
OCF growth 5Y10.31%

IMAFLEX INC / IFX.CA FAQ

What is the fundamental rating for IFX stock?

ChartMill assigns a fundamental rating of 5 / 10 to IFX.CA.


What is the valuation status of IMAFLEX INC (IFX.CA) stock?

ChartMill assigns a valuation rating of 3 / 10 to IMAFLEX INC (IFX.CA). This can be considered as Overvalued.


Can you provide the profitability details for IMAFLEX INC?

IMAFLEX INC (IFX.CA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for IFX stock?

The Earnings per Share (EPS) of IMAFLEX INC (IFX.CA) is expected to grow by 33.33% in the next year.